B of A Securities Maintains Neutral on Inspire Medical Systems, Lowers Price Target to $185
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has maintained a Neutral rating on Inspire Medical Systems (NYSE:INSP) but has lowered the price target from $225 to $185.
June 03, 2024 | 11:55 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
B of A Securities has maintained a Neutral rating on Inspire Medical Systems (NYSE:INSP) but has lowered the price target from $225 to $185. This suggests a cautious outlook on the stock's performance.
The lowered price target from $225 to $185 indicates a less optimistic view on the stock's future performance. This could lead to a negative sentiment among investors, potentially causing a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100